Cell-mediated immunity to vesicular stomatitis virus infections in mice
- PMID: 202522
- DOI: 10.1159/000162882
Cell-mediated immunity to vesicular stomatitis virus infections in mice
Abstract
The T cell-mediated immune responses of mice against vesicular stomatitis virus (VSV) were assessed by measuring direct primary foot pad swelling after local VSV infection and cytotoxic activity in spleens. The cytolytic activity was mediated by T cells since it was anti-theta + complement sensitive, was restricted by the K and D region but not the I region of H-2 and rapidly increased after 4 days but decreased 8 days after systemic or local infection. Cytolytic activity was virus-specific as reciprocally tested with VSV and vaccina virus immune T cells. Measurable activity on day 7 depended on infectious virus dose, virus virulence, and non-H-2 genetic background of the host. More than half of the cytolytic activity wasblocked specifically by either immune anti-H2 or rabbit anti-VSV antisera. Analysis of the kinetics of appearance of antigenic changes using metabolic inhibitors, revealed that the changes that rendered target cells susceptible to lysis after infection, occurred within the first hour after infection.
Similar articles
-
Cross-reactive anti-vesicular stomatitis virus (VSV) cytotoxic T lymphocytes recognize the major surface glycoprotein.Eur J Immunol. 1981 May;11(5):434-6. doi: 10.1002/eji.1830110517. Eur J Immunol. 1981. PMID: 6266837
-
Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.J Immunol. 1990 Aug 1;145(3):985-94. J Immunol. 1990. PMID: 1695651
-
H-2L-restricted recognition of viral antigens In the H-2d haplotype, anti-vesicular stomatitis virus cytotoxic T cells are restricted solely by H-2L.J Exp Med. 1982 Sep 1;156(3):778-90. doi: 10.1084/jem.156.3.778. J Exp Med. 1982. PMID: 6286837 Free PMC article.
-
Target antigens for H-2-restricted vesicular stomatitis virus-specific cytotoxic T cells.J Immunol. 1978 Aug;121(2):744-8. J Immunol. 1978. PMID: 210232
-
Cell mediated immunity in virus infections.Biosci Rep. 1997 Aug;17(4):367-87. doi: 10.1023/a:1027305300453. Biosci Rep. 1997. PMID: 9367053 Review.
Cited by
-
Antibodies against the two serotypes of vesicular stomatitis virus measured by enzyme-linked immunosorbent assay: immunodominance of serotype-specific determinants and induction of asymmetrically cross-reactive antibodies.J Virol. 1987 Aug;61(8):2509-14. doi: 10.1128/JVI.61.8.2509-2514.1987. J Virol. 1987. PMID: 2439706 Free PMC article.
-
Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge.J Virol. 1998 Jun;72(6):4704-11. doi: 10.1128/JVI.72.6.4704-4711.1998. J Virol. 1998. PMID: 9573234 Free PMC article.
-
The Importance of Lassa Fever and Its Disease Management in West Africa.Viruses. 2024 Feb 7;16(2):266. doi: 10.3390/v16020266. Viruses. 2024. PMID: 38400041 Free PMC article. Review.
-
Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses.J Virol. 2004 May;78(10):5458-65. doi: 10.1128/jvi.78.10.5458-5465.2004. J Virol. 2004. PMID: 15113924 Free PMC article.
-
Attenuated vesicular stomatitis viruses as vaccine vectors.J Virol. 1999 May;73(5):3723-32. doi: 10.1128/JVI.73.5.3723-3732.1999. J Virol. 1999. PMID: 10196265 Free PMC article.